REFRACTORY MELANOMA
Clinical trials for REFRACTORY MELANOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MELANOMA trials appear
Sign up with your email to follow new studies for REFRACTORY MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat skin cancer: trial tests custom immune cell therapy
Disease control Recruiting nowThis clinical trial is testing a personalized immunotherapy called DOC1021 for patients with melanoma that has stopped responding to standard treatments. The therapy uses a patient's own immune cells, loaded with markers from their tumor, to train the immune system to attack the …
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Diakonos Oncology Corporation • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New pill targets tough cancers in early safety trial
Disease control Recruiting nowThis is a first-in-human study to find a safe dose of a new oral drug called IACS-6274. It will be tested alone and in two different drug combinations in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the safety …
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
First-in-Human trial tests engineered immune cells to fight tough melanoma
Disease control Recruiting nowThis is an early-stage study to find a safe and effective dose of a new cell therapy for people with advanced melanoma that has come back or stopped responding to standard treatments. Doctors will give participants immune cells (NK cells) that have been specially engineered in a …
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC